Ron Horowitz, CFO
Professional Overview
Ron Horowitz is an accomplished finance executive with over 25 years of experience leading financial operations and strategic initiatives for healthcare organizations. As the Chief Financial Officer at Tennessee Oncology, he oversees all financial activities and drives the company's long-term financial planning and performance.
Experience Summary
Current Role
As the CFO of Tennessee Oncology since 1996, Ron is responsible for managing the organization's financial reporting, budgeting, forecasting, and treasury functions. Under his leadership, he has implemented robust financial controls, streamlined operational processes, and driven strategic decision-making to support the company's growth and profitability. Ron's financial expertise and strategic vision have been instrumental in enabling Tennessee Oncology to deliver high-quality cancer care while maintaining a strong financial position.
Career Progression
Prior to joining Tennessee Oncology, Ron held progressive finance roles at several regional healthcare providers, including serving as the Controller at Vanderbilt University Medical Center and the Director of Finance at Centennial Medical Center. Throughout his career, Ron has demonstrated a strong track record of improving financial performance, optimizing resource allocation, and aligning financial strategies with organizational objectives.
Academic Background
Ron holds a Bachelor of Science in Accounting from the University of Tennessee and a Master of Business Administration from Vanderbilt University. He is a Certified Public Accountant (CPA) and maintains memberships with the American Institute of CPAs and the Tennessee Society of CPAs.
Areas of Expertise
- Financial planning and analysis
- Budgeting and forecasting
- Cash flow management and treasury operations
- Financial reporting and compliance
- Strategic decision-making and business partnering
- Healthcare industry knowledge and regulatory expertise
Professional Impact
Under Ron's financial leadership, Tennessee Oncology has consistently achieved strong financial results, enabling the organization to reinvest in advanced cancer treatment technologies, expand its patient care footprint, and maintain its position as a leading provider of oncology services in the region. Ron's contributions have been instrumental in supporting the company's mission of delivering exceptional patient care and driving innovation in the healthcare industry.
Conclusion
With his extensive experience, strategic mindset, and commitment to financial excellence, Ron Horowitz is a valuable asset to Tennessee Oncology. His expertise in healthcare finance and his ability to align financial strategies with organizational goals make him a trusted advisor and strategic partner to the executive team and the board of directors.
